Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG)

India flag India · Delayed Price · Currency is INR
241.70
-13.00 (-5.10%)
Apr 29, 2026, 3:24 PM IST
73.26%
Market Cap 2.68B
Revenue (ttm) 979.90M
Net Income (ttm) 82.09M
Shares Out 10.52M
EPS (ttm) 7.76
PE Ratio 32.82
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,000
Average Volume 11,860
Open 254.50
Previous Close 254.70
Day's Range 235.00 - 254.50
52-Week Range 125.00 - 335.00
Beta 0.25
RSI 63.60
Earnings Date May 22, 2026

About NSE:MADHAVBAUG

Vaidya Sane Ayurved Laboratories Limited, together with its subsidiaries, engages in the research, development, and sale of ayurvedic medicines and products in India. It operates through Sale of Product and Hospital Activity segments. The company sells medicines for arthritis and joint pains, cholesterol, diabetes, digestive, acidity, gastric, dyslipidemia, fever, cough, cold, general tonic, heart disease, hypertension/high blood pressure, liver, low glycemic index atta, obesity/weight management, piles and renal, skin, and wounds; and diet box... [Read more]

Sector Healthcare
Founded 1999
Employees 636
Stock Exchange National Stock Exchange of India
Ticker Symbol MADHAVBAUG
Full Company Profile

Financial Performance

In fiscal year 2025, NSE:MADHAVBAUG's revenue was 898.47 million, a decrease of -9.55% compared to the previous year's 993.31 million. Earnings were 71.36 million, an increase of 260.34%.

Financial Statements

News

There is no news available yet.